Opus Genetics, Inc. (IRD) Reports Q2 Loss, Lags Revenue Estimates
Opus Genetics, Inc. (IRD) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus…
Jobless Claims Increased More Than Expected
Another full morning of market data to go through today, which will help articulate where we are in…